Cite
HARVARD Citation
Tarantini, G. et al. (2016). Optimal duration of dual antiplatelet therapy after second-generation drug-eluting stent implantation in patients with diabetes: The SECURITY (Second-Generation Drug-Eluting Stent Implantation Followed By Six- Versus Twelve-Month Dual Antiplatelet Therapy)-diabetes substudy. International journal of cardiology. pp. 168-176. [Online].